rs7070148
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001081.4(CUBN):c.593+169T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0882 in 653,454 control chromosomes in the GnomAD database, including 3,576 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.067 ( 512 hom., cov: 32)
Exomes 𝑓: 0.095 ( 3064 hom. )
Consequence
CUBN
NM_001081.4 intron
NM_001081.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.180
Genes affected
CUBN (HGNC:2548): (cubilin) Cubilin (CUBN) acts as a receptor for intrinsic factor-vitamin B12 complexes. The role of receptor is supported by the presence of 27 CUB domains. Cubulin is located within the epithelium of intestine and kidney. Mutations in CUBN may play a role in autosomal recessive megaloblastic anemia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 10-17122626-A-C is Benign according to our data. Variant chr10-17122626-A-C is described in ClinVar as [Benign]. Clinvar id is 1286315.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.228 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0669 AC: 10177AN: 152126Hom.: 513 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
10177
AN:
152126
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0916 AC: 10693AN: 116756 AF XY: 0.101 show subpopulations
GnomAD2 exomes
AF:
AC:
10693
AN:
116756
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0947 AC: 47489AN: 501210Hom.: 3064 Cov.: 3 AF XY: 0.103 AC XY: 28172AN XY: 272392 show subpopulations
GnomAD4 exome
AF:
AC:
47489
AN:
501210
Hom.:
Cov.:
3
AF XY:
AC XY:
28172
AN XY:
272392
Gnomad4 AFR exome
AF:
AC:
264
AN:
13000
Gnomad4 AMR exome
AF:
AC:
1037
AN:
24938
Gnomad4 ASJ exome
AF:
AC:
1856
AN:
16668
Gnomad4 EAS exome
AF:
AC:
608
AN:
29430
Gnomad4 SAS exome
AF:
AC:
12304
AN:
55146
Gnomad4 FIN exome
AF:
AC:
3859
AN:
43380
Gnomad4 NFE exome
AF:
AC:
24825
AN:
287828
Gnomad4 Remaining exome
AF:
AC:
2333
AN:
27130
Heterozygous variant carriers
0
2204
4409
6613
8818
11022
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0668 AC: 10174AN: 152244Hom.: 512 Cov.: 32 AF XY: 0.0703 AC XY: 5230AN XY: 74426 show subpopulations
GnomAD4 genome
AF:
AC:
10174
AN:
152244
Hom.:
Cov.:
32
AF XY:
AC XY:
5230
AN XY:
74426
Gnomad4 AFR
AF:
AC:
0.0198113
AN:
0.0198113
Gnomad4 AMR
AF:
AC:
0.0475693
AN:
0.0475693
Gnomad4 ASJ
AF:
AC:
0.114187
AN:
0.114187
Gnomad4 EAS
AF:
AC:
0.0243056
AN:
0.0243056
Gnomad4 SAS
AF:
AC:
0.239419
AN:
0.239419
Gnomad4 FIN
AF:
AC:
0.0906775
AN:
0.0906775
Gnomad4 NFE
AF:
AC:
0.0830613
AN:
0.0830613
Gnomad4 OTH
AF:
AC:
0.0705492
AN:
0.0705492
Heterozygous variant carriers
0
482
964
1447
1929
2411
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
362
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Oct 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at